Compare McKesson Corporation (MCK) vs NextEra Energy, Inc. (NEE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs NextEra Energy, Inc. — how do they compare? McKesson Corporation trades at $823.62 (market cap $97.35B), while NextEra Energy, Inc. trades at $87.94 (market cap $183.53B). The key difference: NextEra Energy, Inc. is the larger of the two by market cap, and NextEra Energy, Inc. pays the higher dividend (2.83%). Which is the better fit depends on your goals.
| MCK | NEE | |
|---|---|---|
Market Cap | $97.35B | $183.53B |
Sector | Health | Utilities |
52-Week High | $995.69 | $97.88 |
52-Week Low | $659.01 | $69.77 |
Enterprise Value | $101.98B | $285.94B |
Dividend Yield | 0.39% | 2.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
NextEra Energy (NEE) trades at $87.82, down 1.1% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported mixed Q1 2026 earnings, beating estimates with $1.09 EPS versus $1.03 expected, but missed Q4 2025. Revenue for 2025 reached $27.41B with a net income margin of 29.37%. Recent news highlights a planned $59B annual capex through 2032 and a merger filing with Dominion Energy to expand market reach.
Outlook remains positive with analyst consensus price target of $101.88 (16% upside), supported by 66.7% buy ratings. Key risks include high capital expenditures straining cash flow and regulatory hurdles for the Dominion merger. The stock offers growth potential from clean energy investments but faces execution and debt concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →
